Data availability
The original contributions presented in the study were included in the article and supplementary materials. Further inquiries can be directed to the corresponding author.
References
Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health. 2018;2:610–20.
Méndez-Sánchez N, Martínez M, González V, Roldán-Valadez E, Flores MA, Uribe M. Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert’s syndrome. Ann Hepatol. 2002;1:40–3.
Méndez-Sánchez N, Roldán-Valadez E, Flores MA, Cárdenas-Vázquez R, Uribe M. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest. 2001;31:773–80.
Boskabadi H, Maamouri G, Mohsen Zadeh H, Shakeri MT, Ghayour-Mobarhan M, Mohammadi S et al. Comparison of serum zinc level between neonates with jaundice and healthy neonates. SEMJ. 2015;16:e59924.
Mohammadzadeh A, Farhat A, Ghasemian A, Ramezani M, Esmaily H, Musavi BM. Effects of oral zinc sulfate on hyperbilirubinemia in low-birth-weight neonates. IJN. 2016;7:11–5.
Mohammadzadeh A, Farhat AS, Alizadeh Kaseb A, Khorakian F, Ramezani M. Prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial. IJN. 2015;5:6–10.
Khoshnevisasl P, Sadeghzadeh M, Kamali K, Moeinian M. Effect of zinc on hyperbilirubinemia of newborns, a randomized double blinded clinical trial. Curr Health Sci J. 2020;46:250–4.
Kumar A, Bagri NK, Basu S, Asthana RK. Zinc supplementation for neonatal hyperbilirubinemia: a randomized controlled trial. Indian Pediatr. 2014;51:375–8.
Faal G, Khatib Masjedi H, Sharifzadeh G, Kiani Z. Efficacy of zinc sulfate on indirect hyperbilirubinemia in premature infants admitted to neonatal intensive care unit: a double-blind, randomized clinical trial. BMC Pediatr. 2020;20:130.
Beiranvand S, Hosseinabadi R, Firouzi M, Almasian M, Anbari K. Impact of combined oral zinc sulfate and phototherapy on serum bilirubin levels in the term neonates with jaundice. IJN. 2018;9:20–5.
Rana N, Mishra S, Bhatnagar S, Paul V, Deorari AK, Agarwal R. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr. 2011;78:1073–8.
Maamouri G, Boskabadi H, Mafinejad S, Bozorgnia Y, Khakshur A. Efficacy of oral zinc sulfate intake in prevention of neonatal jaundice. IJN. 2014;4:11–6.
Elfarargy MS, Al-Ashmawy GM, Abu-Risha S. Zinc supplementation in preterm neonates with jaundice: is it beneficial? Endocr Metab Immune Disord Drug Targets. 2021;21:1929–34.
Hashemian S, Mohammadzadeh A, Farhat A, Ramezani M, Seyedi SJ. The therapeutic effect of zinc sulfate on neonatal hyperbilirubinemia. IJN. 2017;8:13–7.
Patton P, Rachmadi D, Sukadi A. Effect of oral zinc on hyperbilirubinemia in full term neonates. Paediatr Indones. 2011;51:107–10.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Higgins JPT, Higgins JGS, Jr S. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). Cochrane Collab. 2011. www.handbook.cochrane.org. Accessed 27 Feb 2021.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Funding
None.
Author information
Authors and Affiliations
Contributions
AMA contributed to conceptualization, data curation, formal analysis, investigation, validation, writing of original draft, reviewing and editing. AGA, AB, MRA, ADA, and MD contributed to data curation, investigation, validation, reviewing and editing. AZA contributed to conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of original draft, and reviewing and editing. All the authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Conflict of interest
No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Al-Matary, A., AlGhamdi, A., Alenaze, B. et al. Therapeutic benefits of zinc sulfate on neonatal hyperbilirubinemia. World J Pediatr 18, 300–304 (2022). https://doi.org/10.1007/s12519-022-00532-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-022-00532-6